- Investing Ideas
- /
- Swiss Potentially Undervalued Companies
Swiss Potentially Undervalued Companies
Results
350
14 new
Companies with a Value score of at least 3, ordered by Value score
350 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
LLBN New | CHF 77.20 | 2.7% | 10.8% | CHF 2.4b | CHF 88.00 | PB1.1x | S1.3% | 3.5% | Banks | ||
ENR | CHF 55.54 | -7.3% | 318.1% | CHF 45.8b | CHF 54.23 | PS1.3x | E48.2% | 0% | Capital Goods | ||
CLN | CHF 11.03 | 1.8% | -0.2% | CHF 3.6b | CHF 14.36 | PE30.7x | E32.8% | 3.8% | Materials | ||
ISN | CHF 135.80 | 0.6% | 11.7% | CHF 1.3b | CHF 117.00 | PE15.2x | E-10.4% | 4.1% | Real Estate Management and Development | ||
BSLN New | CHF 45.60 | 11.6% | 26.0% | CHF 553.1m | CHF 76.92 | PE7.1x | E6.5% | 0% | Pharmaceuticals & Biotech | ||
MC | CHF 840.00 | 0% | 0% | CHF 305.2b | CHF 969.72 | PE21.9x | E6.9% | 2.1% | Consumer Durables | ||
C | CHF 68.05 | 0% | 0% | CHF 130.0b | CHF 74.84 | PB0.7x | E30.6% | 3.3% | Banks | ||
MSFT | CHF 4,000.00 | 0% | 0% | CHF 3.1t | CHF 4,823.85 | PE35.1x | E12.4% | 0.8% | Software | ||
ORCL | CHF 58.30 | 0% | 0% | CHF 473.5b | CHF 59.99 | PE43.1x | E16.2% | 0.9% | Software | ||
RIGN | CHF 4.00 | 0% | 0% | CHF 3.7b | CHF 5.05 | PS1.1x | E116.8% | 0% | Energy | ||
VZ | CHF 55.70 | 0% | 0% | CHF 175.3b | CHF 63.29 | PE17.9x | E15.6% | 6.5% | Telecom | ||
SWD | US$12.10 | 0% | -15.4% | US$45.3b | US$13.43 | PE30.5x | E25.7% | 0.5% | Capital Goods | ||
T | CHF 30.00 | 0% | 0% | CHF 191.1b | CHF 30.43 | PE17.8x | E10.2% | 4.2% | Telecom | ||
FME | CHF 41.45 | 0% | n/a | CHF 13.0b | CHF 42.08 | PE19.7x | E16.8% | 2.7% | Healthcare | ||
AG1 | CHF 16.91 | 0% | n/a | CHF 4.2b | CHF 17.21 | PS0.7x | E81.2% | n/a | Retail | ||
VOL1 | CHF 25.46 | 0% | 9.4% | CHF 667.6b | CHF 25.53 | PE13.2x | E4.6% | 5.6% | Capital Goods | ||
000982352 | CHF 133.33 | -0.9% | 15.3% | CHF 181.5b | CHF 159.43 | PE32.6x | E16.5% | 2.1% | Pharmaceuticals & Biotech | ||
VATN | CHF 114.00 | 1.4% | 12.4% | CHF 1.8b | CHF 111.67 | PB0.7x | E1.7% | 5.1% | Banks | ||
SGKN | CHF 474.50 | 1.3% | -4.3% | CHF 2.8b | CHF 520.00 | PB1x | S4.1% | 4.0% | Banks | ||
IDIA | CHF 0.85 | 13.3% | -69.3% | CHF 161.2m | CHF 1.00 | PS1.4x | E17.8% | n/a | Pharmaceuticals & Biotech | ||
ZUGN New | CHF 2,090.00 | -2.8% | 13.9% | CHF 1.1b | CHF 1,950.00 | PE18.2x | E-6.3% | 2.1% | Real Estate Management and Development | ||
KOMN | CHF 128.00 | 0.2% | -20.6% | CHF 655.0m | CHF 175.00 | PE115x | E90.7% | 2.3% | Capital Goods | ||
EJT1 New | CHF 5.43 | -5.4% | -9.8% | CHF 3.7b | CHF 7.75 | PE8.2x | E9.3% | 2.5% | Transportation | ||
DBAN | CHF 33.50 | 0% | 0% | CHF 466.5m | CHF 56.98 | PE27.1x | E54.1% | 3.9% | Diversified Financials |